{"id":"W2107268345","doi":"10.1056/nejmoa062867","title":"Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia","year":2006,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3481,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"Celgene; Pfizer; Kementerian Pendidikan Nasional; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Imatinib; Internal medicine; Cytarabine; Myeloid leukemia; Adverse effect; Imatinib mesylate; Philadelphia chromosome; Alpha interferon; Gastroenterology; Oncology; Surgery; Immunology; Interferon; Chromosomal translocation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006381366,0.0002366292,0.0004568737,0.0004812009,0.0006714656,0.0005419787,0.0002501651,0.0007065665,0.001498871],"category_scores_gemma":[0.002260127,0.0001604975,0.0005362519,0.0004351284,0.0002334969,0.0004925447,0.0003204892,0.0006458333,0.0003430983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004689973,"about_ca_system_score_gemma":0.0003071908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003453243,"about_ca_topic_score_gemma":0.002891198,"domain_scores_codex":[0.9996287,0.00007331587,0.00003556604,0.00007583552,0.00007112154,0.0001154903],"domain_scores_gemma":[0.9986002,0.0002119786,0.0004800865,0.00008510637,0.0001925081,0.0004301707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009628526,0.0001572375,0.9939439,0.000009466217,0.00007579863,0.000383145,0.0001134907,0.0001270028,0.0003438976,0.00001265693,0.0002033183,0.003667234],"study_design_scores_gemma":[0.00008393769,0.001245772,0.9967821,0.00000805962,0.0001066373,0.0006928816,0.00008735425,0.0002936516,0.0001384471,0.00002137501,0.000529681,0.00001007639],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989309,0.0002656311,0.00006075294,0.00005896587,0.000008523647,0.00001400037,0.0002902814,0.000004024309,0.0003669063],"genre_scores_gemma":[0.9992291,0.00004811015,0.00003458968,0.0000508917,0.00001051516,0.00001116678,0.0004260275,6.764119e-7,0.0001888645],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003453243,"threshold_uncertainty_score":0.006866336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01252982675583111,"score_gpt":0.2622417208740349,"score_spread":0.2497118941182038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}